mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.1 |